MacroGenics (MGNX)
(Delayed Data from NSDQ)
$3.56 USD
+0.11 (3.19%)
Updated Sep 10, 2024 04:00 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for MacroGenics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -9.06 | -119.76 | -202.12 | -129.74 | -151.81 |
Depreciation/Amortization & Depletion | 4.64 | 12.27 | 12.87 | 11.70 | 10.85 |
Net Change from Assets/Liabilities | 56.81 | -2.79 | 20.26 | -14.53 | -12.88 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -130.59 | 23.32 | 25.16 | 20.68 | 19.57 |
Net Cash From Operating Activities | -78.21 | -86.96 | -143.83 | -111.90 | -134.27 |
Property & Equipment | -1.70 | -3.62 | -6.20 | -5.91 | -4.29 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -78.38 | 74.34 | -30.41 | -1.88 | -75.07 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -80.08 | 70.72 | -36.61 | -7.79 | -79.36 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.17 | 1.66 | 122.78 | 174.34 | 119.97 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 149.19 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 150.36 | 1.66 | 122.78 | 174.34 | 119.97 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -7.93 | -14.59 | -57.66 | 54.66 | -93.66 |
Cash at Beginning of Period | 108.88 | 123.47 | 181.13 | 126.47 | 220.13 |
Cash at End of Period | 100.96 | 108.88 | 123.47 | 181.13 | 126.47 |
Diluted Net EPS | -0.15 | -1.95 | -3.37 | -2.47 | -3.16 |
Fiscal Year End for MacroGenics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -107.85 | -52.19 | -9.06 | 37.01 | 19.46 |
Depreciation/Amortization & Depletion | 1.40 | 0.53 | 4.64 | 4.47 | 4.39 |
Net Change from Assets/Liabilities | 2.88 | -0.15 | 56.81 | 40.60 | 51.16 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.45 | 6.17 | -130.59 | -132.25 | -89.94 |
Net Cash From Operating Activities | -90.13 | -45.64 | -78.21 | -50.17 | -14.92 |
Property & Equipment | -2.41 | -1.46 | -1.70 | -1.08 | -0.59 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 74.65 | 26.25 | -78.38 | -117.83 | -84.79 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 72.23 | 24.79 | -80.08 | -118.91 | -85.38 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 3.27 | 2.64 | 1.17 | 0.90 | 0.84 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.40 | -2.39 | 149.19 | 149.19 | 99.33 |
Net Cash from Financing Activities | 0.87 | 0.25 | 150.36 | 150.09 | 100.18 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -17.02 | -20.60 | -7.93 | -18.99 | -0.13 |
Cash at Beginning of Period | 100.96 | 100.96 | 108.88 | 108.88 | 108.88 |
Cash at End of Period | 83.93 | 80.36 | 100.96 | 89.90 | 108.76 |
Diluted Net EPS | -0.89 | -0.84 | -0.74 | 0.28 | 0.92 |